ELEVATION ONCOLOGY INC (ELEV) Stock Analyst Ratings
NASDAQ:ELEV - Nasdaq - US28623U1016 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ELEV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.14. This target is 1075.5% above the current price.
ELEV was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ELEV.
In the previous month the buy percentage consensus was at a similar level.
ELEV was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-03 | William Blair | Initiate | Outperform |
| 2024-12-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-06 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-31 | Piper Sandler | Initiate | Overweight |
| 2024-05-14 | Stephens & Co. | Initiate | Overweight |
| 2024-05-03 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | JMP Securities | Initiate | Market Outperform |
| 2024-02-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-06 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-09-29 | HC Wainwright & Co. | Initiate | Buy |
| 2023-06-05 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-05-30 | SVB Securities | Upgrade | Market Perform -> Outperform |
| 2023-03-10 | Wedbush | Reiterate | Outperform |
| 2023-01-09 | SVB Leerink | Maintains | Market Perform |
| 2022-11-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-07 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-08-08 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2022-03-04 | Wedbush | Maintains | Outperform |
| 2021-12-23 | HC Wainwright & Co. | Initiate | Buy |
| 2021-07-20 | SVB Leerink | Initiate | Outperform |
| 2021-07-20 | Cowen & Co. | Initiate | Outperform |